The Michael J. Fox Foundation’s Program to Speed Parkinson’s Research Using Improved In Vivo Models

High-quality, accessible preclinical models are vital for Parkinson’s disease research and therapeutic development. The Michael J. Fox Foundation (MJFF) actively designs, validates, and distributes such reagents and models to ensure these models and associated research reagents are available. MJFF has partnered with Taconic for the past decade to generate and/or distribute critical rodent models for Parkinson’s disease research. The availability of these models has led to breakthroughs in the field, empowering research and speeding us toward a cure. On our 10-year partnership anniversary, MJFF and Taconic are excited to announce the development of a host of additional Parkinson’s disease-related rodent models, most of which will be made available to the community in 2025.